Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

Clinical pharmacokinetics and safety of novel sPLA2 inhibitor examined in severe sepsis

July 2, 1999

New sublingual beta-blocker enters phase IIb trial in angina pectoris

July 1, 1999

Novel tyrphostins with antiproliferative activity via inhibition of PDGF receptor tyrosine kinase

July 1, 1999

Nitroderivative of aspirin endowed with significant myocardial protective effects

June 30, 1999

Piperidines synthesized at Toa Eiyo act as 5-HT2 antagonists and antiplatelet agents

June 30, 1999

New benzothiophene ET antagonists from Pfizer

June 30, 1999

Bradykinin mimic reduces myocardial infarct size in rat model

June 29, 1999

Antiischemic and cytoprotective agents from Taisho act via inhibition of Na+/Ca2+ exchange

June 29, 1999

Adenosine binding and uptake inhibitors in the Kyowa Hakko pipeline

June 29, 1999

Antiarrhythmic drug to move into phase II trials at CV Therapeutics

June 29, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 10, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld
Hematopoietic stem cell research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
Korsana boosts Alzheimer’s work with reverse merger, $380M financing
BioWorld Science
Just over a month after emerging from stealth and disclosing a $150 million series A, Korsana Biosciences Inc. is making the leap to the public market via a...